Seoul Pharma Co. Ltd Free Cash Flow Generation Index
Seoul Pharma Co. Ltd free cash flow generation index. Seoul Pharma Co. Ltd (018680) has a Free Cash Flow Generation Index of 0.96x as of June 2025. Free cash flow of ₩1.98 Billion represents 1% of operating cash flow (₩2.07 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Seoul Pharma Co. Ltd (2009–2023)
Free cash flow generation index of Seoul Pharma Co. Ltd from 2009 to 2023. Historical FCF Generation Index trend for Seoul Pharma Co. Ltd across 8 annual periods. See Seoul Pharma Co. Ltd (018680) flexibility index to measure the company's free cash flow as a share of total liabilities.
Seoul Pharma Co. Ltd Free Cash Flow Generation Index by Year (2009–2023)
Seoul Pharma Co. Ltd free cash flow generation index by year from 2009 to 2023. Year-by-year Free Cash Flow Generation Index for Seoul Pharma Co. Ltd. For the full cash flow conversion analysis, see 018680 cash flow conversion.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.64x | ₩3.37 Billion | ₩5.26 Billion | ₩1.89 Billion | ▼ -27.5% |
| 2020 | 0.88x | ₩5.07 Billion | ₩5.74 Billion | ₩671.25 Million | ▼ -16.2% |
| 2019 | 1.05x | ₩3.09 Billion | ₩2.93 Billion | ₩156.43 Million | ▼ -46.9% |
| 2015 | 1.98x | ₩2.82 Billion | ₩1.42 Billion | ₩1.40 Billion | ▼ -28.5% |
| 2014 | 2.77x | ₩4.10 Billion | ₩1.48 Billion | ₩2.62 Billion | ▼ -5.9% |
| 2012 | 2.95x | ₩27.17 Billion | ₩9.22 Billion | ₩17.95 Billion | ▲ +39.1% |
| 2011 | 2.12x | ₩10.29 Billion | ₩4.86 Billion | ₩5.43 Billion | ▼ -64.4% |
| 2009 | 5.95x | ₩7.34 Billion | ₩1.23 Billion | ₩6.11 Billion | — |